Simvastatin
Product Images NDC 53808-0790

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Simvastatin (NDC 53808-0790). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 10 mg (Simvastatin 10mg (lupin))

Simvastatin 10 mg tablets prescription label showing a quantity of 30 tablets. The label includes a lot number, expiration date, and states packaging by DOH Central Pharmacy in Tallahassee, FL. A barcode with UPC 368180478027 is also visible. Manufacturer name Lupin Pharm is mentioned on the label.*

FDA Label Image

Label Image For 20 mg (Simvastatin 20 mg(lupin))

Simvastatin 20 mg tablet label showing a quantity of 30 tablets. The label indicates the product is prescription only and is packaged by DOH Central Pharmacy in Tallahassee, FL. The manufacturer is Lupin Ltd. A lot number and expiration date are also displayed along with a UPC barcode.*

FDA Label Image

Label Image For 40 mg (Simvastatin 40mg (lupin))

Label for simvastatin 40 mg tablet with a quantity of 30 tablets. The label includes text indicating RX only, manufacturer Lupin Ltd., packaging by DOH Central Pharmacy in Tallahassee, FL. Also shows lot numbers, expiration date, and a UPC barcode.*

FDA Label Image

Molecular Formula (Simvastatintablet 01)

Chemical structure of simvastatin, illustrating the molecular arrangement of atoms and bonds characteristic of this active ingredient.*

FDA Label Image

Chart 1 (Simvastatintablet 02)

A clinical data chart comparing the incidence (%) of major vascular events and major coronary events between simvastatin and placebo groups. The chart presents risk ratios with confidence intervals (95% CI) across various patient subgroups including diabetes status, peripheral vascular disease, cerebrovascular disease, gender, age, and cholesterol levels (LDL and HDL). The horizontal axis shows the risk ratio favoring either simvastatin or placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.